Analysed SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) News Sources
Spruce Biosciences (SPRB) Appoints Dale Hooks as CCO and Reports Narrowed $39M 2025 Net Loss
17-03-2026
yahoo.com
Does Spruce Biosciences (SPRB) Have the Potential to Rally 208.32% as Wall Street Analysts Expect?
18-03-2026
yahoo.com
Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade
03-04-2026
yahoo.com
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
08-06-2026
yahoo.com
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller
15-06-2026
yahoo.com
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Dynatrace, Emerson Electric, Exxon Mobil, Flutter Entertainment, Genuine Parts, nVent Electric, Palantir Technologies, Roku, and More
16-06-2026
247wallst.com
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
22-06-2026
yahoo.com
What is the current price of SPRUCE BIOSCIENCES INC (SPRB:NASDAQ)?
The current price of SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) is $50.07.
SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) since the previous trading day is $-1.67.
SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) since the previous trading day is -3.2277%.
What is the most recent average sentiment score for SPRUCE BIOSCIENCES INC (SPRB:NASDAQ)?
The most recent average sentiment score for SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for SPRUCE BIOSCIENCES INC (SPRB:NASDAQ)?
The most recent sentiment for SPRUCE BIOSCIENCES INC (SPRB:NASDAQ) is .
SEC-8K** Filing Available For SPRUCE BIOSCIENCES INC (SPRB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.